Bedriye Seda Kurşun Aktar

Bedriye Seda Kurşun Aktar

Auto-generated profile, based on publicly available information

Bedriye Seda Kurşun Aktar

Malatya Turgut Özal University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2025 in ACS Omega
Verified
Journal Article
Open access
BABedriye Seda Kurşun Aktar
Bedriye Seda Kurşun Aktar
YSYusuf Sıcak
Yusuf Sıcak
ABAbdulkadir Bakırdöven
Abdulkadir Bakırdöven
GYGizem Tatar Yılmaz
Gizem Tatar Yılmaz
ÖYÖzlem Yılmaz
Özlem Yılmaz
EOEmine Elçin Oruç-Emre
Emine Elçin Oruç-Emre
A series of chalcones containing a pyrrolidine moiety were synthesized to examine their in vitro α-amylase and α-glucosidase inhibitory activities, for the treatment of Diabetes mellitus, which is one of the most dangerous and rapidly increasing disorders of today. Compound 3 exhibited an excellent dual inhibitory effect with an IC50 value of 14.61 ± 0.12 μM against α-amylase, and with an IC50: 25.38 ± 2.09 μM against α-glucosidase. The in vitro cytotoxic effects of all compounds against nonsmall lung cancer (A549) and bronchial epithelial normal (BEAS-2B) cell lines were also evaluated. Compound 5 (IC50: 82.20 μM) and compound 8 (IC50: 59.96 μM) showed better cytotoxic activity than cisplatin against A549 (IC50: 84.39 μM) cells. Furthermore, these compounds had no harmful effect on healthy BEAS-2B cells at the determined IC50 values. Moreover, the molecular docking and molecular dynamics simulation analysis revealed that all synthesized compounds exhibited stronger binding affinities toward α-glucosidase and α-amylase compared to the positive control acarbose.

25 September 2024 in ACS Omega
Verified
Journal Article
Open access
BABedriye Seda Kurşun Aktar
Bedriye Seda Kurşun Aktar
In this study, it was aimed to synthesize (E)-N'-(2-hydroxybenzylidene)-substituted benzenesulfonohydrazide (1-7) from the 2-hydroxybenzaldehyde reaction of different substituted fluorinated sulfonyl hydrazides. The structures of the synthesized molecules were characterized by elemental analysis, FTIR, 1H NMR, 13C NMR, 19F NMR, and 2D NMR (HMBC, correlation spectroscopy, and HQSC). The anticholinesterase (AChE and BChE) and antidiabetic (α-glucosidase, α-amylase) inhibition activities of the synthesized compounds were evaluated. According to biological activity test results, (E)-N'-(2-hydroxybenzylidene)-4-(trifluoromethoxy)benzenesulfonohydrazide (compound 7 among hydrazone derivatives 1-7) demonstrated better BChE inhibitor activity than galantamine in anticholinesterase inhibition; and in the α-glucosidase and α-amylase assay, it exhibited more antidiabetic inhibition activity than the reference standard.

13 July 2022 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
BABedriye Seda Kurşun Aktar
Bedriye Seda Kurşun Aktar
YSYusuf Sıcak
Yusuf Sıcak
GTGizem Tatar
Gizem Tatar
EOEmine Elçin Oruç-Emre
Emine Elçin Oruç-Emre

1 January 2021 in TURKISH JOURNAL OF CHEMISTRY
Verified
Journal Article
Open access
BABedriye Seda Kurşun Aktar
Bedriye Seda Kurşun Aktar
YSYusuf Sicak
Yusuf Sicak
GTGizem Tatar
Gizem Tatar
EOEmine Elçin Oruç-Emre
Emine Elçin Oruç-Emre
Hydrazone compounds have high capacity in terms of antioxidant activity and enzyme inhibition activities such as anticholinesterase, tyrosinase, and urease. In this study, benzoyl hydrazones compounds (7a–7m) were synthesized starting from 3,5-dimethoxy-4-hydroxybenzaldehyde. Antioxidant activity of the synthesized compounds was evaluated. In the β-carotene-linoleic acid and ABTS cation radical scavenging activities, compounds 7j, 7e, and 7m stood out as the most active compounds, respectively. In the anticholinesterase enzyme inhibition activity results, compound 7f exhibited the best activity against AChE and BChE enzymes in the synthesis series. In addition, molecular docking analysis was performed to understand the inhibition mechanism of the synthesized compounds with target enzymes at the atomic level. In the light of biological activity and in silico studies, it has the potential to guide studies for the development of new drugs for Alzheimer disease in the future.

30 April 2025 in Journal of Molecular Structure
Verified
Journal Article
Closed access
BABedriye Seda Kurşun Aktar
Bedriye Seda Kurşun Aktar
ŞAŞevki Adem
Şevki Adem
EEEmel Ekinci
Emel Ekinci
EOEmine Elçin Oruç-Emre
Emine Elçin Oruç-Emre

19 September 2025 in ACS Omega
Verified
Journal Article
Open access
BABedriye Seda Kurşun Aktar
Bedriye Seda Kurşun Aktar
YSYusuf Sıcak
Yusuf Sıcak
EOEmine Elçin Oruç-Emre
Emine Elçin Oruç-Emre
RKRabia Kılıç
Rabia Kılıç
ESEbru Sağlam
Ebru Sağlam
AYAyse Sahin Yaglioglu
Ayse Sahin Yaglioglu
Diabetes mellitus affects over 500 million people globally and is expected to rise significantly in the coming decades. Existing antidiabetic drugs, including α-glucosidase and α-amylase inhibitors, often exhibit side effects and limited efficacy, prompting the search for safer alternatives. Hydrazone derivatives have shown promising antidiabetic activity due to their structural diversity and enzyme-targeting potential. In this study, 10 novel hydrazone compounds were synthesized and evaluated for their inhibitory effects against α-amylase and α-glucosidase. Compounds 8 and 10 showed the highest dual inhibition: compound 8 with IC50 = 30.21 ± 0.16 μM (α-amylase) and 38.06 ± 0.80 μM (α-glucosidase); compound 10 with IC50 = 34.49 ± 0.37 and 40.44 ± 0.23 μM, respectively. Cytotoxicity on HEK293 cells via MTT assay revealed IC50 values of 61.04 μM (compound 7) and 69.25 μM (compound 9), while other compounds and acarbose were nontoxic up to 100 μM. In silico drug-likeness analysis showed that 80% of the compounds complied with Lipinski's rules, with topological polar surface area (TPSA) values ranging between 63 and 112 Å2. Gastrointestinal absorption was high for 7 out of 10 compounds; none showed blood-brain barrier permeability. Molecular docking confirmed strong binding interactions of compounds 8 and 10 with both enzymes' active sites. These findings highlight hydrazone scaffolds as potent and safe candidates for further antidiabetic drug development.